Published mark

ClearPoint Neuro, Inc.

NASDAQ: CLPT. ClearPoint Neuro, Inc. is a medical technology firm primarily operating within the United States.

US

Record source reportedRecord not claimedNo Eval published
Follow companySave PDF
Alpha ID
alpha:company:0ec501c5-0069-42c7-b1a3-e45364681e9f
SEC CIK
0001285550
Record version
vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce, published Oct 25, 2026
Newest evidence
Apr 10, 2026
Monitoring
Not yet monitored Details
Integrity
Not yet signed Methodology
CEO
Joseph M. BurnettChief Executive Officer and President
Chair
R. John Fletcher
Independent
Not published5 directors published
Published claims
182 distinct sources
Evidence records
40 pinned
Source conflicts
0None open

Built from 2 distinct sources and 4 evidence records. Every Claim links to where it appears. Where nothing was published, the record states the coverage gap.

CorroboratedSource reportedAlpha inferenceNot disclosed

Public record. Alpha publishes governance facts about this organization from regulatory filings and company statements. Private enterprise overlay data is never projected here. The company can claim the record, correct, or dispute any Claim. How this works

DIRECTOR APPOINTED

Linda M. Liau seat on ClearPoint Neuro, Inc., effective 2021-01-01.

EffectiveEffective Jan 1, 2021E3

Monitoring

Continuous

What the published record states about identity, evidence, evaluation, monitoring, authority, and freshness. Watched-source schedules are not published for this record.

  • Identityunclaimed
    Published
  • Evidencesource_reported
    Published
  • Evaluationnot_evaluated
    Published
  • MonitoringNot yet published for this record.
    Not published
  • AuthorityNot yet published for this record.
    Not published
  • Freshnesscurrent
    Published

Leadership

Evidence
RolePersonSinceStatusClaim
Chief Financial OfficerDanilo D'AlessandroNot capturedunknownSource reportedE2
Chief Business OfficerJeremy L. StigallNot capturedunknownSource reportedE2
Chief Executive Officer and PresidentJoseph M. BurnettNot capturedunknownSource reportedE2

Board of directors

Evidence

5 directors published. Independence determinations are not published for every director.

DirectorStatusSinceCommitteesClaim
B. Kristine JohnsonIndependence not published2019None publishedSource reportedE3
Linda M. LiauIndependence not published2021None publishedSource reportedE3
Lynnette C. FallonIndependence not published2021Audit Committee, chairSource reportedE3
Matthew B. KleinIndependence not published2020None publishedSource reportedE3
Timothy T. RichardsIndependence not published2014None publishedSource reportedE3
Joseph M. BurnettNot independentNot publishedPresident and DirectorSource reportedE2
R. John FletcherIndependentChairNot publishedNone publishedSource reportedE2

Committees and risk ownership

Evidence
CommitteeChairMembersRisks assigned
Audit CommitteeLynnette C. FallonLynnette C. FallonNot described in the published record
President and DirectorNot publishedJoseph M. BurnettNot described in the published record
Committee RecordAudit Committee: Chair Lynnette C. Fallon; Members Lynnette C. Fallon (Chair)
Committee AppointmentLynnette C. Fallon: chair, Audit Committee

Control and voting power

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

Authority to act

Evidence and agent registry

Who can act for the company, and on whose authority. This is what a counterparty's agent checks before it accepts an order, signs, or pays.

Principal executive officerJoseph M. Burnett, Chief Executive Officer and President
Who can authorize an agentNot assessedNo Alpha inference about signing authority or board-reserved matters is published for this record.
Not assessed
bind
AI agents registered by the companyNot registered in the public RegistryAgent Deployments, Agent Use Cases, Authority Grants, TrustChecks, Action Ledger entries and Governance Receipts live in the private enterprise overlay. They are never projected into the public Registry without explicit cross-plane authorization. Absence here is a plane boundary, not evidence that the enterprise operates no agents.
Agent registry
agents
Delegations publishedNot disclosedBoard and officer delegation resolutions are not public filings and are not published in this record.
Search scope
delegations

Financials and market context

Evidence
Security ListingCLPT (NASDAQ)
Index membershipsNo current membership is published in Alpha's tracked index universe.This is not evidence that the company is absent from every market index.
None publishedAs of Oct 25, 2026. Rights-filtered public evidence only; no redistribution or model training is granted. Only source-backed memberships with an explicit public redistribution basis are returned.

Governance and policies

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

Risk, audit, and cyber

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

AI oversight and accountability

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

Compensation

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

Other published claims

Evidence

Published Claims that belong to no section above. Each keeps its permalink, evidence, and assertion state.

Legal NameClearPoint Neuro, Inc.
Entity StatusPublic listing published
Published FactHealthcare
Published FactMedical - Devices

Not yet in this record

Coverage

A gap is a coverage state, not a negative finding. These sections are expected for this entity class and are not yet published.

  • Corporate structureNot reviewed. Parent, subsidiary and predecessor structure explains who is governed.
  • OwnershipNot reviewed. Ownership and voting power determine who can influence the board.
  • FinancialsNot reviewed. Governance-relevant financial context frames capital and audit decisions.
  • CompensationNot reviewed. Pay design shows how incentives are governed.
  • GovernanceNot reviewed. Governing documents and provisions set the rules of the enterprise.
  • Shareholder governanceNot reviewed. Meeting and vote records show shareholder dissent and support.
  • AuditNot reviewed. Auditor, controls and restatements show assurance over reporting.
  • LegalNot reviewed. Material legal and regulatory matters show enforcement exposure.
  • RiskNot reviewed. Risk ownership links the board, committees, executives and controls.
  • CyberNot reviewed. Cyber and data governance is a disclosed oversight domain.
  • AI governanceNot reviewed. AI oversight is a differentiated Alpha governance domain.
  • Markets externalNot reviewed. Auditors, advisors, investors and regulators form the external ecosystem.
  • Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
  • Only explicitly published canonical company identity and current confirmed public roles are included.Only explicitly published canonical company identity and current confirmed public roles are included.
  • Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
  • Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
  • This Company Profile is an identity and evidence record, not an Alpha rating.This Company Profile is an identity and evidence record, not an Alpha rating.

Subject and corrections

Public-role doctrine

This record exists because the company is in the published Registry. The company can claim the record, correct, or dispute any Claim. Corrections are versioned and the original stays in history.

Basis
Published company record built from public sources
Sources
4 evidence records cited. 0 with redistribution rights.
Never published
Private enterprise overlay data: deployments, authority grants, TrustChecks, receipts, telemetry
Record claimed
No
Open disputes
0
Identity ownership
unclaimed
Claiming not yet available

If the company claims the record, its statements appear as their own assertion state and never overwrite the cited evidence.

Evidence

Authority and rights
  1. E1
    Alpha canonical company public projection. canonical identity. Retrieved Oct 25, 2026. Cited by 6 Claims.
    Open web
    Rights not recorded, link only
    Evidence not pinned
  2. E2
    sec def 14a. Published Apr 10, 2026. Retrieved Sep 6, 2026. Cited by 5 Claims.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  3. E3
    sec proxy. Published Apr 10, 2026. Retrieved Sep 2, 2026. Cited by 5 Claims.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  4. E4
    governance_people_committees. sec proxy. Cited by 2 Claims.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned

What changed in version public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce

vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce published Oct 25, 2026
  • Linda M. Liau seat on ClearPoint Neuro, Inc., effective 2021-01-01.
  • Lynnette C. Fallon seat on ClearPoint Neuro, Inc., effective 2021-01-01.
  • Matthew B. Klein seat on ClearPoint Neuro, Inc., effective 2020-01-01.
  • B. Kristine Johnson seat on ClearPoint Neuro, Inc., effective 2019-01-01.
  • Timothy T. Richards seat on ClearPoint Neuro, Inc., effective 2014-01-01.
Appearance

Alpha Governance PBC. The Registry records reported facts and Alpha's assessments separately. A missing fact is not evidence that it is false.

Record alpha:company:0ec501c5-0069-42c7-b1a3-e45364681e9f, version public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce. https://registry.alpha.ac/companies/clearpoint-neuro-inc

Navigate

esc
  • Actions
    Switch to agent viewJSON, Markdown, MCP
  • Copy Alpha IDalpha:company:0ec501c5-0069-42c7-b1a3-e45364681e9f
  • Cite this recordClearPoint Neuro, Inc.
  • Copy canonical URLregistry.alpha.ac/companies/clearpoint-neuro-inc
  • Copy as MarkdownWith assertion states
  • Report an error
  • Theme: System
  • Theme: Light
  • Theme: Dark
  • Records
    ClearPoint Neuro, Inc.Company
  • Danilo D'AlessandroPerson
  • Jeremy L. StigallPerson
  • Joseph M. BurnettPerson
  • B. Kristine JohnsonPerson
  • Linda M. LiauPerson
  • Lynnette C. FallonPerson
  • Matthew B. KleinPerson
  • Timothy T. RichardsPerson
  • R. John FletcherPerson
  • Sections
    OverviewClearPoint Neuro, Inc.
  • MonitoringClearPoint Neuro, Inc.
  • LeadershipClearPoint Neuro, Inc.
  • BoardClearPoint Neuro, Inc.
  • CommitteesClearPoint Neuro, Inc.
  • Control and votingClearPoint Neuro, Inc.
  • Authority to actClearPoint Neuro, Inc.
  • FinancialsClearPoint Neuro, Inc.
  • GovernanceClearPoint Neuro, Inc.
  • RiskClearPoint Neuro, Inc.
  • AI oversightClearPoint Neuro, Inc.
  • LegalClearPoint Neuro, Inc.
  • CompensationClearPoint Neuro, Inc.
  • Other published claimsClearPoint Neuro, Inc.
  • Coverage gapsClearPoint Neuro, Inc.
  • Linked peopleClearPoint Neuro, Inc.
  • Subject and correctionsClearPoint Neuro, Inc.
  • EvidenceClearPoint Neuro, Inc.
  • Version historyClearPoint Neuro, Inc.
↑ ↓ move↵ openThis record only

Report an error

Reports attach to the Claim and go to an Alpha analyst through the correction form. Corrections are versioned, and the original stays in history.